Select Page


PrimeVigilance is a subsidiary of Ergomed plc. PrimeVigilance is managed by its own Board of Directors which includes leading pharmacovigilance experts with extensive experience as regulators and also running pharmaceutical and biotechnology companies.

Dr Miroslav Reljanovic

Dr. Miroslav Reljanovic is a medical doctor and a board-certified neurologist. Whilst practicing as a physician in a large WHO Collaborating Centre in Zagreb, he was the clinical investigator in numerous Phase II and III studies in the field of neurology and a consultant to various pharmaceutical companies. In 1997 Miro founded Ergomed and he introduced the novel Study Site Coordination model as an intrinsic part of the conduct of clinical studies… Read more


Dr. Jan Petracek is an expert in pharmacovigilance and risk management. He is the former Head of Risk Management Section at the European Medicines Agency, and the former Head of Pharmacovigilance… Read more

Neil Clark

On leaving PWC in 1997 he joined CeNeS Pharmaceuticals plc and was Chief Finance Officer and then Chief Executive of CeNeS which was listed in London until its sale in 2008…Read more

Natalie Smith – COO

Natalie Smith Chief Operatin Officer has 19 years Pharmacovgillance experience of which 8 years were in creating a Global PV department in an orphan drug rare diseases company… Read more

The Senior Management includes:

Ida Schnabel – Director Global Pharmacovigilance Operation

Ida is a Senior Executive with a long lasting experience in the pharmaceutical industry, including branded, generic, prescription and OTC drugs…Read more